How does tirzepatide differ from semaglutide?

Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide targets only GLP-1. Phase 3 data indicate tirzepatide produces greater average weight reduction, though individual responses vary.

What dosing schedule did clinical trials use?

SURMOUNT-1 used once-weekly subcutaneous injections starting at 2.5mg and escalating every four weeks up to 5mg, 10mg, or 15mg maintenance doses over 72 weeks.

What reconstitution solvent is recommended?

Bacteriostatic water (BW) is standard. Use 1-2ml per vial and swirl gently without shaking to avoid degradation.

Bestseller

Tirzepatide

Name: Tirzepatide
Price: 40 USD
Availability: InStock

Dual GIP and GLP-1 receptor agonist. Among the most potent metabolic peptides studied to date, with clinical trials reporting up to 21% body weight reduction.

Fat LossGH Boost

● In Stock

Select Variant

Quantity (vials)

Buy more, save more

—

1+ vials

−5%

3+ vials

−10%

5+ vials

−20%

10+ vials

Total Price

$40

For research & laboratory use only. Not for human consumption.

Half-Life

5 days

Administration Route

Subcutaneous injection

Dual Receptor Action

Targets GLP-1 & GIP simultaneously for superior fat loss

22.5% Body Weight Loss

Best-in-class efficacy proven in Phase 3 SURMOUNT trial

Cardiovascular Protection

Reduces HbA1c and improves lipid profile

Effect Profile

Based on primary research mechanisms

Fat Loss

Hunger Control

Metabolic Health

Energy

Effect Timeline

Start

Appetite noticeably reduced, portion sizes decrease naturally

Week 4

3–5% body weight loss; blood sugar stabilising

Week 8

Visible fat loss, especially around waist; energy stable

Week 16

8–12% weight loss achieved; metabolic markers improved

Start — Week 1–2